Acute exacerbation of rheumatoid arthritis–associated interstitial lung disease: clinical features and prognosis

Abstract Objectives RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD. Methods We retrospectively collected data on 165 RA-ILD patients who vis...

Full description

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 60; no. 5; pp. 2348 - 2354
Main Authors Izuka, Shinji, Yamashita, Hiroyuki, Iba, Arisa, Takahashi, Yuko, Kaneko, Hiroshi
Format Journal Article
LanguageEnglish
Published England Oxford University Press 14.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Objectives RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD. Methods We retrospectively collected data on 165 RA-ILD patients who visited or were admitted to our hospital between January 2007 and December 2019. We compared the clinical characteristics of patients who did and did not develop ILD-AE and identified variables significantly associated with ILD-AE. We also compared the admission characteristics of those who survived and those who died after admission for ILD-AE. ILD-AE was defined using previously proposed criteria, modified slightly for application to RA-ILD. Results The mean patient age was 73.6 years (s.d. 9.7) and 97 (71.9%) patients were female. Thirty (22.2%) patients developed ILD-AE, 13 (43.3%) of whom died. In univariate analyses, neither the usual interstitial pneumonia (UIP) pattern nor MTX was associated with ILD-AE. In multivariate analyses, the UIP pattern was significantly associated with ILD-AE [odds ratio (OR) 2.55 (95% CI 1.05, 6.20), P = 0.038]. In the Cox proportional hazards model, the UIP pattern [hazard ratio (HR) 4.67 (95% CI 1.02, 21.45), P = 0.048] was significantly associated with death, while MTX use [HR 0.16 (95% CI 0.04, 0.72), P = 0.016] was significantly associated with survival. Conclusion Our data suggest that the UIP pattern is related to ILD-AE. Furthermore, both the UIP pattern and non-use of MTX might be related to death from ILD-AE in RA-ILD.
AbstractList RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD. We retrospectively collected data on 165 RA-ILD patients who visited or were admitted to our hospital between January 2007 and December 2019. We compared the clinical characteristics of patients who did and did not develop ILD-AE and identified variables significantly associated with ILD-AE. We also compared the admission characteristics of those who survived and those who died after admission for ILD-AE. ILD-AE was defined using previously proposed criteria, modified slightly for application to RA-ILD. The mean patient age was 73.6 years (s.d. 9.7) and 97 (71.9%) patients were female. Thirty (22.2%) patients developed ILD-AE, 13 (43.3%) of whom died. In univariate analyses, neither the usual interstitial pneumonia (UIP) pattern nor MTX was associated with ILD-AE. In multivariate analyses, the UIP pattern was significantly associated with ILD-AE [odds ratio (OR) 2.55 (95% CI 1.05, 6.20), P = 0.038]. In the Cox proportional hazards model, the UIP pattern [hazard ratio (HR) 4.67 (95% CI 1.02, 21.45), P = 0.048] was significantly associated with death, while MTX use [HR 0.16 (95% CI 0.04, 0.72), P = 0.016] was significantly associated with survival. Our data suggest that the UIP pattern is related to ILD-AE. Furthermore, both the UIP pattern and non-use of MTX might be related to death from ILD-AE in RA-ILD.
Abstract Objectives RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD. Methods We retrospectively collected data on 165 RA-ILD patients who visited or were admitted to our hospital between January 2007 and December 2019. We compared the clinical characteristics of patients who did and did not develop ILD-AE and identified variables significantly associated with ILD-AE. We also compared the admission characteristics of those who survived and those who died after admission for ILD-AE. ILD-AE was defined using previously proposed criteria, modified slightly for application to RA-ILD. Results The mean patient age was 73.6 years (s.d. 9.7) and 97 (71.9%) patients were female. Thirty (22.2%) patients developed ILD-AE, 13 (43.3%) of whom died. In univariate analyses, neither the usual interstitial pneumonia (UIP) pattern nor MTX was associated with ILD-AE. In multivariate analyses, the UIP pattern was significantly associated with ILD-AE [odds ratio (OR) 2.55 (95% CI 1.05, 6.20), P = 0.038]. In the Cox proportional hazards model, the UIP pattern [hazard ratio (HR) 4.67 (95% CI 1.02, 21.45), P = 0.048] was significantly associated with death, while MTX use [HR 0.16 (95% CI 0.04, 0.72), P = 0.016] was significantly associated with survival. Conclusion Our data suggest that the UIP pattern is related to ILD-AE. Furthermore, both the UIP pattern and non-use of MTX might be related to death from ILD-AE in RA-ILD.
RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD.OBJECTIVESRA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and risk factors of ILD-AE and mortality of RA-ILD.We retrospectively collected data on 165 RA-ILD patients who visited or were admitted to our hospital between January 2007 and December 2019. We compared the clinical characteristics of patients who did and did not develop ILD-AE and identified variables significantly associated with ILD-AE. We also compared the admission characteristics of those who survived and those who died after admission for ILD-AE. ILD-AE was defined using previously proposed criteria, modified slightly for application to RA-ILD.METHODSWe retrospectively collected data on 165 RA-ILD patients who visited or were admitted to our hospital between January 2007 and December 2019. We compared the clinical characteristics of patients who did and did not develop ILD-AE and identified variables significantly associated with ILD-AE. We also compared the admission characteristics of those who survived and those who died after admission for ILD-AE. ILD-AE was defined using previously proposed criteria, modified slightly for application to RA-ILD.The mean patient age was 73.6 years (s.d. 9.7) and 97 (71.9%) patients were female. Thirty (22.2%) patients developed ILD-AE, 13 (43.3%) of whom died. In univariate analyses, neither the usual interstitial pneumonia (UIP) pattern nor MTX was associated with ILD-AE. In multivariate analyses, the UIP pattern was significantly associated with ILD-AE [odds ratio (OR) 2.55 (95% CI 1.05, 6.20), P = 0.038]. In the Cox proportional hazards model, the UIP pattern [hazard ratio (HR) 4.67 (95% CI 1.02, 21.45), P = 0.048] was significantly associated with death, while MTX use [HR 0.16 (95% CI 0.04, 0.72), P = 0.016] was significantly associated with survival.RESULTSThe mean patient age was 73.6 years (s.d. 9.7) and 97 (71.9%) patients were female. Thirty (22.2%) patients developed ILD-AE, 13 (43.3%) of whom died. In univariate analyses, neither the usual interstitial pneumonia (UIP) pattern nor MTX was associated with ILD-AE. In multivariate analyses, the UIP pattern was significantly associated with ILD-AE [odds ratio (OR) 2.55 (95% CI 1.05, 6.20), P = 0.038]. In the Cox proportional hazards model, the UIP pattern [hazard ratio (HR) 4.67 (95% CI 1.02, 21.45), P = 0.048] was significantly associated with death, while MTX use [HR 0.16 (95% CI 0.04, 0.72), P = 0.016] was significantly associated with survival.Our data suggest that the UIP pattern is related to ILD-AE. Furthermore, both the UIP pattern and non-use of MTX might be related to death from ILD-AE in RA-ILD.CONCLUSIONOur data suggest that the UIP pattern is related to ILD-AE. Furthermore, both the UIP pattern and non-use of MTX might be related to death from ILD-AE in RA-ILD.
Author Izuka, Shinji
Takahashi, Yuko
Kaneko, Hiroshi
Yamashita, Hiroyuki
Iba, Arisa
Author_xml – sequence: 1
  givenname: Shinji
  orcidid: 0000-0002-9724-4911
  surname: Izuka
  fullname: Izuka, Shinji
  organization: Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan
– sequence: 2
  givenname: Hiroyuki
  orcidid: 0000-0002-0022-1941
  surname: Yamashita
  fullname: Yamashita, Hiroyuki
  email: hiroyuki_yjp2005@yahoo.co.jp
  organization: Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan
– sequence: 3
  givenname: Arisa
  surname: Iba
  fullname: Iba, Arisa
  organization: Department of Public Health, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
– sequence: 4
  givenname: Yuko
  surname: Takahashi
  fullname: Takahashi, Yuko
  organization: Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan
– sequence: 5
  givenname: Hiroshi
  surname: Kaneko
  fullname: Kaneko, Hiroshi
  organization: Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33241299$$D View this record in MEDLINE/PubMed
BookMark eNqNkc9OGzEQxq0KVP6-QYV85JLG9jq7Xm5RBG2lSL1wX816Z4NhYwePV4Ib78Ab9klqmgRVvZTTjL75fTPSfCfswAePjH2R4qsUdTGNdziuIYUhrJ6nDwhQCvOJHUtdqokoCnXw3it9xE6I7oUQM1mYz-woj7VUdX3M4tyOCTk-gcXYQnLB89Dz_XLXcYjpLrrk6NfLKxAF6yBhx51PGCnlAQx8GP2Kd44QCK-4HZx3Nss9QhojEgff8U0MKx_I0Rk77GEgPN_VU3Z7c327-D5Z_vz2YzFfTmxRajUB0LqVtdClhFaZrrKqtmhsZdrSVqq1BqAyWeq07vusVCWYblZXvZgJqItTdrldmw8_jkipWTuyOAzgMYzUKF3qUlRGVhm92KFju8au2US3hvjc7N-UAb0FbAxEEft3RIrmLY3m7zSaXRrZdvWPzbr058cpghv-Z55uzWHcfOzcbxYBrFM
CitedBy_id crossref_primary_10_1055_a_1550_3882
crossref_primary_10_1016_j_autrev_2022_103056
crossref_primary_10_7759_cureus_30145
crossref_primary_10_1016_j_resinv_2023_02_007
crossref_primary_10_1186_s40001_023_01384_0
crossref_primary_10_1186_s13075_021_02586_9
crossref_primary_10_2169_naika_112_1920
crossref_primary_10_1016_j_rcreue_2023_09_002
crossref_primary_10_1186_s12890_023_02532_2
crossref_primary_10_1097_CM9_0000000000002577
crossref_primary_10_1016_j_reumae_2022_03_004
crossref_primary_10_1055_s_0042_1755566
crossref_primary_10_1093_rheumatology_kead363
crossref_primary_10_1111_1756_185X_14351
crossref_primary_10_1016_j_rcreu_2023_09_006
crossref_primary_10_3389_fmed_2024_1465753
crossref_primary_10_1097_RTI_0000000000000734
crossref_primary_10_1186_s13075_024_03453_z
crossref_primary_10_1002_JLB_3MA1221_489R
crossref_primary_10_1186_s12931_022_01978_y
crossref_primary_10_3390_diagnostics14171890
crossref_primary_10_1007_s00296_020_04773_4
crossref_primary_10_1513_AnnalsATS_202305_491OC
crossref_primary_10_1183_23120541_00403_2024
crossref_primary_10_3390_diagnostics14131430
crossref_primary_10_47360_1995_4484_2022_1
crossref_primary_10_1093_mr_roac115
crossref_primary_10_1016_j_rmed_2022_106898
crossref_primary_10_1016_j_semarthrit_2022_152031
crossref_primary_10_1093_rheumatology_keac651
crossref_primary_10_1093_rheumatology_kead027
crossref_primary_10_1080_17476348_2022_2089116
crossref_primary_10_1002_acr2_11736
crossref_primary_10_3389_fphar_2022_941013
crossref_primary_10_1016_j_chstcc_2023_100020
crossref_primary_10_1177_1759720X221074457
crossref_primary_10_1186_s13075_021_02578_9
crossref_primary_10_7759_cureus_48016
crossref_primary_10_1016_j_rmcr_2023_101857
crossref_primary_10_1007_s10067_023_06623_7
crossref_primary_10_1016_j_ebiom_2024_105339
crossref_primary_10_1016_j_autrev_2023_103501
crossref_primary_10_1016_j_reuma_2022_03_005
crossref_primary_10_1016_j_autrev_2025_103804
crossref_primary_10_1298_ptr_E10188
crossref_primary_10_1038_s41584_021_00721_z
crossref_primary_10_3389_fmed_2023_1129939
crossref_primary_10_7759_cureus_41155
crossref_primary_10_1186_s12864_023_09548_2
crossref_primary_10_58877_japaj_v2i1_125
crossref_primary_10_1002_jmv_29781
Cites_doi 10.3899/jrheum.101261
10.1016/j.rmed.2008.12.019
10.1016/j.rmed.2012.07.006
10.3904/kjim.2016.349
10.1093/rheumatology/keq035
10.1378/chest.07-0323
10.1080/03009740601153774
10.1002/art.1780310302
10.1136/bmjopen-2018-028466
10.1007/s00296-010-1665-1
10.1093/rheumatology/keg466
10.1016/j.reuma.2011.12.008
10.1183/16000617.0050-2017
10.1001/archinternmed.2007.59
10.1164/rccm.2009-040GL
10.1002/art.38733
10.1164/rccm.200703-463PP
10.1093/rheumatology/kez337
10.1093/rheumatology/41.3.262
10.1007/s10067-015-3025-8
10.1038/s41584-019-0275-x
10.1002/art.27584
10.1093/rheumatology/kez177
10.1056/NEJMoa1801562
10.1136/bmjopen-2013-003132
10.3109/14397595.2016.1173816
10.1378/chest.09-0444
10.1002/art.1780401016
10.1002/art.27405
10.1378/chest.103.6.1808
ContentType Journal Article
Copyright The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020
The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020
– notice: The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1093/rheumatology/keaa608
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1462-0332
EndPage 2354
ExternalDocumentID 33241299
10_1093_rheumatology_keaa608
10.1093/rheumatology/keaa608
Genre Journal Article
GroupedDBID ---
-E4
.2P
.GJ
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29P
2WC
354
3O-
4.4
48X
53G
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAGKA
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABQTQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
AQDSO
ATGXG
ATTQO
AXUDD
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
KAQDR
KBUDW
KC5
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MHKGH
N9A
NGC
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBH
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RHF
RIG
RNI
ROL
ROX
RUSNO
RW1
RXO
RZF
RZO
SV3
TCURE
TEORI
TJX
TMA
TR2
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZGI
ZKX
ZY1
~91
AAYXX
ABDFA
ABEJV
ABGNP
ABVGC
ADNBA
AEMQT
AGORE
AHGBF
AHMMS
AJBYB
AJNCP
ALXQX
CITATION
JXSIZ
NPM
7X8
ID FETCH-LOGICAL-c3642-aa44b190461ab28d7c29ce8c78b6c72bc8aa789ced44ffc7276a8d597f050a93
ISSN 1462-0324
1462-0332
IngestDate Fri Jul 11 04:49:12 EDT 2025
Thu Apr 03 07:09:37 EDT 2025
Tue Jul 01 04:04:20 EDT 2025
Thu Apr 24 23:10:58 EDT 2025
Wed Aug 28 03:18:56 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords MTX
acute exacerbation
usual interstitial pneumonia
interstitial lung disease
RA
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3642-aa44b190461ab28d7c29ce8c78b6c72bc8aa789ced44ffc7276a8d597f050a93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9724-4911
0000-0002-0022-1941
PMID 33241299
PQID 2464607817
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2464607817
pubmed_primary_33241299
crossref_primary_10_1093_rheumatology_keaa608
crossref_citationtrail_10_1093_rheumatology_keaa608
oup_primary_10_1093_rheumatology_keaa608
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-May-14
PublicationDateYYYYMMDD 2021-05-14
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-May-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Rheumatology (Oxford, England)
PublicationTitleAlternate Rheumatology (Oxford)
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Zamora-Legoff (2021051419010939900_keaa608-B28) 2017; 56
Kondoh (2021051419010939900_keaa608-B33) 2017; 26
Hozumi (2021051419010939900_keaa608-B6) 2013; 3
Aletaha (2021051419010939900_keaa608-B10) 2010; 62
Kondoh (2021051419010939900_keaa608-B3) 1993; 103
Restrepo (2021051419010939900_keaa608-B21) 2015; 34
Arnett (2021051419010939900_keaa608-B9) 1988; 31
Kiely (2021051419010939900_keaa608-B22) 2019; 9
Fragoulis (2021051419010939900_keaa608-B24) 2019; 58
Wolfe (2021051419010939900_keaa608-B17) 2007; 36
Juge (2021051419010939900_keaa608-B32) 2018; 379
Ota (2021051419010939900_keaa608-B7) 2017; 27
Suda (2021051419010939900_keaa608-B4) 2009; 103
Gochuico (2021051419010939900_keaa608-B15) 2008; 168
Kim (2021051419010939900_keaa608-B26) 2009; 136
Rojas-Serrano (2021051419010939900_keaa608-B23) 2014; 66
Koduri (2021051419010939900_keaa608-B19) 2010; 49
Duarte (2021051419010939900_keaa608-B25) 2019; 58
Saravanan (2021051419010939900_keaa608-B11) 2003; 43
Zou (2021051419010939900_keaa608-B20) 2012; 32
Dawson (2021051419010939900_keaa608-B18) 2002; 41
Yang (2021051419010939900_keaa608-B27) 2019; 34
Mori (2021051419010939900_keaa608-B30) 2012; 106
Park (2021051419010939900_keaa608-B5) 2007; 132
Bongartz (2021051419010939900_keaa608-B1) 2010; 62
Collard (2021051419010939900_keaa608-B2) 2007; 176
Rojas-Serrano (2021051419010939900_keaa608-B8) 2012; 8
Gaffo (2021051419010939900_keaa608-B16) 2008; 168
Aubart (2021051419010939900_keaa608-B29) 2011; 38
Song (2021051419010939900_keaa608-B14) 2013; 30
Wang (2021051419010939900_keaa608-B31) 2019; 15
Raghu (2021051419010939900_keaa608-B13) 2011; 183
Kremer (2021051419010939900_keaa608-B12) 1997; 40
References_xml – volume: 38
  start-page: 979
  year: 2011
  ident: 2021051419010939900_keaa608-B29
  article-title: High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.101261
– volume: 168
  start-page: 1927
  year: 2008
  ident: 2021051419010939900_keaa608-B16
  article-title: Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis
  publication-title: Arch Intern Med
– volume: 103
  start-page: 846
  year: 2009
  ident: 2021051419010939900_keaa608-B4
  article-title: Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2008.12.019
– volume: 106
  start-page: 1591
  year: 2012
  ident: 2021051419010939900_keaa608-B30
  article-title: Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2012.07.006
– volume: 34
  start-page: 434
  year: 2019
  ident: 2021051419010939900_keaa608-B27
  article-title: Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis
  publication-title: Korean J Intern Med
  doi: 10.3904/kjim.2016.349
– volume: 49
  start-page: 1483
  year: 2010
  ident: 2021051419010939900_keaa608-B19
  article-title: Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keq035
– volume: 132
  start-page: 214
  year: 2007
  ident: 2021051419010939900_keaa608-B5
  article-title: Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis
  publication-title: Chest
  doi: 10.1378/chest.07-0323
– volume: 36
  start-page: 172
  year: 2007
  ident: 2021051419010939900_keaa608-B17
  article-title: Rheumatoid arthritis treatment and the risk of severe interstitial lung disease
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009740601153774
– volume: 31
  start-page: 315
  year: 1988
  ident: 2021051419010939900_keaa608-B9
  article-title: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780310302
– volume: 9
  start-page: e028466
  year: 2019
  ident: 2021051419010939900_keaa608-B22
  article-title: Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2018-028466
– volume: 32
  start-page: 669
  year: 2012
  ident: 2021051419010939900_keaa608-B20
  article-title: The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-010-1665-1
– volume: 56
  start-page: 344
  year: 2017
  ident: 2021051419010939900_keaa608-B28
  article-title: Patterns of interstitial lung disease and mortality in rheumatoid arthritis
  publication-title: Rheumatology (Oxford)
– volume: 43
  start-page: 143
  year: 2003
  ident: 2021051419010939900_keaa608-B11
  article-title: Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/keg466
– volume: 8
  start-page: 68
  year: 2012
  ident: 2021051419010939900_keaa608-B8
  article-title: Interstitial lung disease related to rheumatoid arthritis: evolution after treatment
  publication-title: Reumatol Clin
  doi: 10.1016/j.reuma.2011.12.008
– volume: 26
  start-page: 170050
  year: 2017
  ident: 2021051419010939900_keaa608-B33
  article-title: Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
  publication-title: Eur Respir Rev
  doi: 10.1183/16000617.0050-2017
– volume: 168
  start-page: 159
  year: 2008
  ident: 2021051419010939900_keaa608-B15
  article-title: Progressive preclinical interstitial lung disease in rheumatoid arthritis
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2007.59
– volume: 183
  start-page: 788
  year: 2011
  ident: 2021051419010939900_keaa608-B13
  article-title: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.2009-040GL
– volume: 66
  start-page: 2641
  year: 2014
  ident: 2021051419010939900_keaa608-B23
  article-title: Methotrexate and lung disease in rheumatoid arthritis: comment on the article by Conway et al
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38733
– volume: 176
  start-page: 636
  year: 2007
  ident: 2021051419010939900_keaa608-B2
  article-title: Acute exacerbations of idiopathic pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200703-463PP
– volume: 58
  start-page: 1900
  year: 2019
  ident: 2021051419010939900_keaa608-B24
  article-title: Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kez337
– volume: 41
  start-page: 262
  year: 2002
  ident: 2021051419010939900_keaa608-B18
  article-title: Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests [published correction appears in Rheumatology (Oxford) 2002 May; 41(5):597]
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/41.3.262
– volume: 34
  start-page: 1529
  year: 2015
  ident: 2021051419010939900_keaa608-B21
  article-title: Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-015-3025-8
– volume: 15
  start-page: 581
  year: 2019
  ident: 2021051419010939900_keaa608-B31
  article-title: Mechanisms of lung disease development in rheumatoid arthritis
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-019-0275-x
– volume: 62
  start-page: 2569
  year: 2010
  ident: 2021051419010939900_keaa608-B10
  article-title: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27584
– volume: 58
  start-page: 2031
  year: 2019
  ident: 2021051419010939900_keaa608-B25
  article-title: The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kez177
– volume: 379
  start-page: 2209
  year: 2018
  ident: 2021051419010939900_keaa608-B32
  article-title: MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1801562
– volume: 30
  start-page: 103
  year: 2013
  ident: 2021051419010939900_keaa608-B14
  article-title: Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia
  publication-title: Sarcoidosis Vasc Diffuse Lung Dis
– volume: 3
  start-page: e003132
  year: 2013
  ident: 2021051419010939900_keaa608-B6
  article-title: Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-003132
– volume: 27
  start-page: 22
  year: 2017
  ident: 2021051419010939900_keaa608-B7
  article-title: Efficacy of intensive immunosuppression in exacerbated rheumatoid arthritis-associated interstitial lung disease
  publication-title: Mod Rheumatol
  doi: 10.3109/14397595.2016.1173816
– volume: 136
  start-page: 1397
  year: 2009
  ident: 2021051419010939900_keaa608-B26
  article-title: Rheumatoid arthritis–associated interstitial lung disease: the relevance of histopathologic and radiographic pattern
  publication-title: Chest
  doi: 10.1378/chest.09-0444
– volume: 40
  start-page: 1829
  year: 1997
  ident: 2021051419010939900_keaa608-B12
  article-title: Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780401016
– volume: 62
  start-page: 1583
  year: 2010
  ident: 2021051419010939900_keaa608-B1
  article-title: Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.27405
– volume: 103
  start-page: 1808
  year: 1993
  ident: 2021051419010939900_keaa608-B3
  article-title: Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases
  publication-title: Chest
  doi: 10.1378/chest.103.6.1808
SSID ssj0005138
Score 2.3609214
Snippet Abstract Objectives RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical...
RA-associated interstitial lung disease (RA-ILD) is commonly associated with acute exacerbations (ILD-AE). This study examined the clinical characteristics and...
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2348
Title Acute exacerbation of rheumatoid arthritis–associated interstitial lung disease: clinical features and prognosis
URI https://www.ncbi.nlm.nih.gov/pubmed/33241299
https://www.proquest.com/docview/2464607817
Volume 60
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NjtMwELbKIiEuiP_tLiAjcUBC2U0c54_bih-1oOUARVpOkeM4asiSoLSRlj3xDjwZr8CTMI4dx9WCtnBo1LiJo3q-jMfjmW8QehLkGY8zEjuy_JsjVwhOlnjE4TQqApJ7OQlk7vDxu3D2kb45CU4mk59W1FK3zg74-R_zSv5HqtAGcpVZsv8gWdMpNMB3kC8cQcJw3ErGR1zu8oszxmFwjO3XLkUHdmhT5pLBaNmzFg0xDT7T4hB5zxTRylAB6TQ_hZd-2K2RXgKTMVmInvpzpRkFGhmYV65sm_a9fl5P5iTZS8-GgHldIcTyNszPu6o3Vz8sy_pzaXQO-yKLOilLdla2zbeuMj_OM-X7lXTAo6OhkrlofUXiZ5-6qrG9F8STG-_e6L38S1akpZBpSBzXV3nWB8Ju8ze0uKpKoNEa2CrZV1SeenonviKtvjB1KFqt1hoyOK0EY6Ebj5OlCWG87JYr6CqBlYssqvFy_naMOvL64urmbw3ZnIl_aPdzqHvZsJY2MjAvLIR6g2hxE93QKxl8pGB5C01EfRtdO9axGndQ26MT2-jETYFHdGKDzl_ff4y4xDYuscQl1rh8jgdU4gGVGOCFDSrvosXrV4sXM0dX-HC4DwtfhzFKMzBJaegxUBh5xEnCRcyjOAt5RECNMBbF0JRTWhTQEoUszmENXLiByxL_Htqpm1rsIpwERQyGFaeEw4cIRlzB4KrcCzIiAneK_GEgU67Z72URltNURWH4qT38qR7-KXLMXV8V-8sl1z8FGW156eNBkClodLlNx2rRdKuU0JCGkoMrmqL7SsKmRwA9BQs92dv-Qfvo-vjiPUA767YTD8GQXmePemj-Bk-g1w0
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+exacerbation+of+rheumatoid+arthritis%E2%80%93associated+interstitial+lung+disease%3A+clinical+features+and+prognosis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Izuka%2C+Shinji&rft.au=Yamashita%2C+Hiroyuki&rft.au=Iba%2C+Arisa&rft.au=Takahashi%2C+Yuko&rft.date=2021-05-14&rft.pub=Oxford+University+Press&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=60&rft.issue=5&rft.spage=2348&rft.epage=2354&rft_id=info:doi/10.1093%2Frheumatology%2Fkeaa608&rft.externalDocID=10.1093%2Frheumatology%2Fkeaa608
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon